West Pharmaceutical Services Inc
NYSE:WST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
West Pharmaceutical Services Inc
NYSE:WST
|
US |
|
Azure Power Global Ltd
OTC:AZREF
|
IN |
|
M
|
Mackolik Internet Hizmetleri Ticaret AS
IST:MACKO.E
|
TR |
|
T
|
Ta Yang Group Holdings Ltd
HKEX:1991
|
CN |
|
W
|
WSFS Financial Corp
XBER:WF4
|
US |
Wall Street
Price Targets
WST Price Targets Summary
West Pharmaceutical Services Inc
According to Wall Street analysts, the average 1-year price target for
WST
is 328.99 USD
with a low forecast of 267.65 USD and a high forecast of 393.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WST's stock price target?
Price Target
328.99
USD
According to Wall Street analysts, the average 1-year price target for
WST
is 328.99 USD
with a low forecast of 267.65 USD and a high forecast of 393.75 USD.
What is West Pharmaceutical Services Inc's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
West Pharmaceutical Services Inc's revenue is
7%.
The projected
CAGR
for the next 3 years is
7%.
What is West Pharmaceutical Services Inc's Operating Income forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
West Pharmaceutical Services Inc's operating income is
13%.
The projected
CAGR
for the next 3 years is
11%.
What is West Pharmaceutical Services Inc's Net Income forecast?
Projected CAGR
14%
For the last 14 years the
compound annual growth rate for
West Pharmaceutical Services Inc's net income is
14%.
The projected
CAGR
for the next 3 years is
14%.
